A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Opis bibliograficzny
1. autor:	Shehab, Habibul Mohsin
Kolejni autorzy:	Yasmin, Hasina
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2024
Hasła przedmiotowe:	Pharmacovigilance Rivastigmine Alzheimer's disease Dementia Pharmacoepidemiology. Mortality. Alzheimer's disease.
Dostęp online:	http://hdl.handle.net/10361/22683

Podobne zapisy

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Wydane: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
od: Mahee, Sadique Abdal
Wydane: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
od: Alim, Abdul
Wydane: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
od: Karmaker, Swastika
Wydane: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
od: Jahan, Nusrat
Wydane: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
od: Ishrat, Nowshin
Wydane: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
od: Bakar, Osama Bin Abu
Wydane: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
od: Chowdhury, Sariya Uzrat
Wydane: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
od: Islam, Md. Irfath
Wydane: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
od: Saha, Bithi Rani
Wydane: (2023)

Alzheimer's disease and marriage : an intimate account /
od: Wright, Lore K.
Wydane: (1993)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
od: Hassan, Md. Muhtaz
Wydane: (2020)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
od: Tasneem, Sadia
Wydane: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
od: Tamanna, Mst. Taskia
Wydane: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
od: Tasin, Md Abtahi
Wydane: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
od: Aziz, Farhin
Wydane: (2019)

An ambient assisted living system for Alzheimer’s patients
od: Abedin, Minhajul, i wsp.
Wydane: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
od: Afra, Sumaiya
Wydane: (2022)

Marine compounds in the treatment of Alzheimer’s disease
od: Parveen, Sanjana
Wydane: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
od: Halim, Rabea
Wydane: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
od: Aana, Afsara Sumon
Wydane: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
od: Rahman, Quazi Ashikur, i wsp.
Wydane: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
od: Mostofa, Golam
Wydane: (2022)

Gene editing for neurodegenerative diseases-A review
od: Sharna, Anika Islam
Wydane: (2023)

A review on adult neurogenesis in Alzheimer’s disease
od: Akter, Moriam
Wydane: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
od: Zaman, Rubaiyat
Wydane: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
od: Haque, Mushfiqul
Wydane: (2019)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
od: Roy, Aditya, i wsp.
Wydane: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
od: Dey, Manashi
Wydane: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
od: Sani, Mehedi Hasan, i wsp.
Wydane: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
od: Alam, Badrul, i wsp.
Wydane: (2016)

Role of circular RNA in neurological disease
od: Salsabil, Labiba
Wydane: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
od: Mahbub, Riasat, i wsp.
Wydane: (2022)

Skeleton /
od: Parkin, Peter

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
od: Nusrat, Tanzina
Wydane: (2019)

হার্ট, ব্লাড, ফুড /
od: কাসেম, এম এ

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
od: Rahman, Ahadina
Wydane: (2018)

Management of Diabetes patients during COVID-19
od: Pantho, G. M. Golam Mehebub
Wydane: (2021)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
od: Nour, Sabrina
Wydane: (2019)

Detection of alzheimer's disease using deep learning
od: Hasan, Mahmudul, i wsp.
Wydane: (2021)